Steady-state plasma and bronchopulmonary concentrations of intravenous levofloxacin and azithromycin in healthy adults

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 8, 2003, Pages 2450-2457

  Rodvold, Keith A ^a,b   Danziger, Larry H ^a,b   Gotfried, Mark H ^a,c,d  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^d Pulmonary Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; LEVOFLOXACIN;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BRONCHOSCOPY; BRONCHUS MUCOSA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; DRUG INFUSION; FEMALE; HUMAN; HUMAN EXPERIMENT; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; MALE; NORMAL HUMAN; OPEN STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; VEIN PUNCTURE;

ADULT; ALGORITHMS; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; AREA UNDER CURVE; AZITHROMYCIN; BLOOD UREA NITROGEN; BRONCHI; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOSCOPY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; EPITHELIUM; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; LUNG; MACROPHAGES, ALVEOLAR; MALE; OFLOXACIN;

EID: 0041767551     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.8.2450-2457.2003     Document Type: Article

References (43)

1. Andrews, J. M., D. Honeybourne, G. Jevons, N. P. Brenwald, B. Cunningham, and R. Wise. 1997. Concentrations of levofloxacin (HR 355) in the respiratory tract following a single oral dose in patients undergoing fibre-optic bronchoscopy. J. Antimicrob. Chemother. 40:573-577.
2. Baldwin, D. R., R. Wise, J. M. Andrews, et al. 1990. Azithromycin concentrations at the sites of pulmonary infection. Eur. Respir. J. 3:886-890.
3. Baldwin, D. R., D. Honeybourne, and R. Wise. 1992. Pulmonary disposition of antimicrobial agents: methodological considerations. Antimicrob. Agents Chemother. 36:1171-1175.
4. Baldwin, D. R., D. Honeybourne, and R. Wise. 1992. Pulmonary disposition of antimicrobial agents: observations and clinical relevance. Antimicrob. Agents Chemother. 36:1176-1180.
5. Bartlett, J. G., S. F. Dowell, L. A. Mandell, T. M. File, D. M. Musher, and M. J. Fine. 2000. Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clin. Infect. Dis. 31:347-382.
6. Bonnet, M., and P. Van der Auwera. 1992. In vitro and in vivo intraleukocytic accumulation of azithromycin (CP-62,993) and its influence on ex vivo leukocyte chemiluminescence. Antimicrob. Agents Chemother. 36:1302-1309.
7. Cazzola, M., C. Siniscalchi, A. Vinciguerra, G. Santangelo, M. G. Matera, and F. Rossi. 1994. Evaluation of lung tissue and hilar lymph node concentrations of azithromycin. Int. J. Clin. Pharmacol. Ther. 32:88-91.
8. Chien, S.-C., M. C. Rogge, L. G. Gisclon, C. Curtin, F. Wong, J. Natarajan, R. R. Williams, C. L. Fowler, W. K. Cheung, and A. T. Chow. 1997. Pharmacokinetic profile of levofloxacin following once-daily 500-milligram oral or intravenous doses. Antimicrob. Agents Chemother. 41:2256-2260.
9. Child, J., D. Mortiboy, J. M. Andrews, A. T. Chow, and R. Wise. 1995. Open-label crossover study to determine pharmacokinetics and penetration of two dose regimens of levofloxacin into inflammatory fluid. Antimicrob. Agents Chemother. 39:2749-2751.
10. Chow, A. T., C. L. Fowler, R. R. Williams, S. V. Callery-D'Amico, R. R. Williams, R. Nayak, and A. T. Chow. 2001. Safety and pharmacokinetics of multiple 750-milligram doses of intravenous levofloxacin in healthy volunteers. Antimicrob. Agents Chemother. 45:2122-2125.
11. Conte, J. E., J. Golden, S. Duncan, E. McKenna, E. Lin, and E. Zurlinden. 1996. Single-dose intrapulmonary pharmacokinetics of azithromycin, clarithromycin, ciprofloxacin, and cefuroxime in volunteer subjects. Antimicrob. Agents Chemother. 40:1617-1622.
12. Conte, J. E., J. A. Golden, J. Kipps, E. T. Lin, and E. Zurlinden. 2001. Effects of AIDS and gender on steady-state plasma and intrapulmonary ethambutol concentrations. Antimicrob. Agents Chemother. 45:2891-2896.
13. Craig, W. A. 2001. Re-evaluating current antibiotic therapy. Respir. Med. 95(Suppl. A):S12-S19.
14. Drusano, G. L., S. L. Preston, M. H. Gotfried, L. H. Danziger, and K. A. Rodvold. 2002. Levofloxacin penetration into epithelial lining fluid as determined by population pharmacokinetic modeling and Monte Carlo simulation. Antimicrob. Agents Chemother. 46:586-589.
15. File, T. M., J. Segreti, L. Dunbar, R. Player, R. Kohler, R. R. Williams, C. Kojak, and A. Rubin. 1997. A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia. Antimicrob. Agents Chemother. 41:1965-1972.
16. Firsov, A. A., S. H. Zinner, S. N. Vostrov, O. V. Kononenko, Y. A. Portnoy, L. V. Shustova, and I. B. Kadenatsi. 2002. Comparative pharmacodynamics of azithromycin and roxithromycin with S. pyogenes and S. pneumoniae in a model that simulates in vitro pharmacokinetics in human tonsils. J. Antimicrob. Chemother. 49:113-119.
17. Fogarty, C., R. Goldschmidt, and K. Bush. 2000. Bacteremic pneumonia due to multidrug-resistant pneumococci in 3 patients treated unsuccessfully with azithromycin and successfully with levofloxacin. Clin. Infect. Dis. 31:613-615.
18. Freeman, C. D., C. H. Nightingale, D. P. Nicolau, P. P. Belliveau, M. A. Banevicius, and R. Quintiliani. 1994. Intracellular and extracellular penetration of azithromycin into inflammatory and noninflammatory blister fluid. Antimicrob. Agents Chemother. 38:2449-2451.
19. Fujita, A., T. Miya, R. Tanaka, S. Hirayama, H. Isaka, Y. Ono, Y. Koshiishi, and T. Goya. 1999. Levofloxacin concentrations in serum, sputum and lung tissue: evaluation of its efficacy according to breakpoint. Jpn. J. Antibiot. 52:661-666.
20. Gotfried, M. H., L. H. Danziger, and K. A. Rodvold. 2001. Steady-state plasma and intrapulmonary concentrations of levofloxacin and ciprofloxacin in healthy adult subjects. Chest 119:1114-1122.
21. Granneman, G. R., and L. L. Varga. 1991. High-performance liquid chromatographic procedures for the determination of temafloxacin in biological matrices. J. Chromatogr. 568:197-206.
22. Hand, W. L., R. M. Boozer, and N. L. King-Thompson. 1985. Antibiotic uptake by alveolar macrophages of smokers. Antimicrob. Agents Chemother. 27:42-45.
23. Kelley, M. A., D. J. Weber, P. Gilligan, and M. S. Cohen. 2000. Breakthrough pneumococcal bacteremia in patients being treated with azithromycin and clarithromycin. Clin. Infect. Dis. 31:1008-1011.
24. Lee, L. J., X. Sha, M. H. Gotfried, J. R. Howard, R. K. Dix, and D. N. Fish. 1998. Penetration of levofloxacin into lung tissues after oral administration to subjects undergoing lung biopsy or lobectomy. Pharmacotherapy 18:35-41.
25. Lipsky, B. A., and C. A. Baker. 1999. Fluoroquinolone toxicity profile: a review focusing on newer agents. Clin. Infect. Dis. 28:352-364.
26. Luke, D. R., G. Foulds, S. F. Cohen, and B. Levy. 1996. Safety, toleration, and pharmacokinetics of intravenous azithromycin. Antimicrob. Agents Chemother. 40:2577-2581.
27. Luke, D. R., and G. Foulds. 1997. Disposition of oral azithromycin in humans. Clin. Pharmacol. Ther. 61:641-648.
28. Metropolitan Life Insurance Company. 1983. Metropolitan height and weight tables. Stat. Bull. 64:2-9.
29. Morris, D. L., A. De Souza, J. A. Jones, and W. E. Morgan. 1991. High and prolonged pulmonary tissue concentrations of azithromycin following a single oral dose. Eur. J. Clin. Microbiol. Infect. Dis. 10:859-861.
30. Niederman, M. S., L. A. Mandell, A. Anzueto, J. B. Bass, W. A. Broughton, G. D. Campbell, N. Dean, T. File, M. J. Fine, P. A. Gross, F. Martinez, T. J. Marrie, J. F. Plouffe, J. Ramirez, G. A. Sarosi, A. Torres, R. Wilson, and V. L. Yu. 2001. Guidelines for the management of adults with community-acquired pneumonia: diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am. J. Respir. Crit. Care Med. 163:1730-1754.
31. Nix, D. E. 1998. Intrapulmonary concentrations of antimicrobial agents. Infect. Dis. Clin. North. Am. 12:631-646.
32. Olsen, K. M., G. S. San Pedro, L. P. Gann, P. O. Gubbins, D. M. Halinski, and G. D. Campbell. 1996. Intrapulmonary pharmacokinetics of azithromycin in healthy volunteers given five oral doses. Antimicrob. Agents Chemother. 40:2582-2585.
33. Patel, K. B., D. Xuan, P. R. Tessier, J. H. Russomanno, R. Quintiliani, and C. H. Nightingale. 1996. Comparison of bronchopulmonary pharmacokinetics of clarithromycin and azithromycin. Antimicrob. Agents Chemother. 40: 2375-2379.
34. Plouffe, J., D. B. Schwartz, A. Kolokathis, B. W. Sherman, P. M. Arnow, J. A. Gezon, B. Suh, A. Anzuetto, R. N. Greenberg, M. Niederman, J. A. Paladino, J. A. Ramirez, J. Inverso, C. A. Knirsch, and the Azithromycin Intravenous Clinical Trials Group. 2000. Clinical efficacy of intravenous followed by oral azithromycin monotherapy in hospitalized patients with community-acquired pneumonia. Antimicrob. Agents Chemother. 44:1796-1802.
35. Preston, S. L., G. L. Drusano, A. L. Berman, C. L. Fowler, A. T. Chow, B. Dornseif, V. Reichl, J. Natarajan, F. A. Wong, and M. Corrado. 1998. Levofloxacin population pharmacokinetics and creation of a demographic model for prediction of individual drug clearance in patients with serious community-acquired infection. Antimicrob. Agents Chemother. 42:1098-1104.
36. Rodvold, K. A., M. H. Gotfried, L. H. Danziger, and R. J. Servi. 1997. Intrapulmonary steady-state concentrations of clarithromycin and azithromycin in healthy adult volunteers. Antimicrob. Agents Chemother. 41:1399-1402.
37. Rodvold, K. A., and M. Neuhauser. 2001. Pharmacokinetics and pharmacodynamics of fluoroquinolones. Pharmacotherapy 21(Suppl. 2):233S-252S.
38. Rodvold, K. A. 2001. Pharmacodynamics of antiinfective therapy: taking what we know to the patient's bedside. Pharmacotherapy 21(Suppl. 2):319S-330S.
39. Shepard, R. M., G. S. Duthu, R. A. Ferraina, and M. A. Mullins. 1991. High-performance liquid chromatographic assay with electrochemical detection for azithromycin in serum and tissues. J. Chromatogr. 565:321-337.
40. Vergis, E. N., A. Indorf, T. M. File, J. Phillips, J. Bates, J. Tan, G. A. Sarosi, J. T. Grayston, J. Summersgill, and V. L. Yu. 2000. Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalized patients: a prospective, randomized, multicenter trial. Arch. Intern. Med. 160:1294-1300.
41. Von Baum, H., S. Bottcher, H. Hoffmann, and H. G. Sonntag. 2001. Tissue penetration of a single dose of levofloxacin intravenously for antibiotic prophylaxis in lung surgery. J. Antimicrob. Chemother. 47:729-730.
42. Waterer, G. W., R. G. Wunderink, and C. B. Jones. 2000. Fatal pneumococcal pneumonia attributed to macrolide resistance and azithromycin monotherapy. Chest 118:1839-1840.
43. West, M., B. R. Boulanger, C. Fogarty, A. Tennenberg, B. Wiesinger, M. Oross, S.-C. Wu, C. Fowler, N. Morgan, and J. B. Kahn. 2003. Levofloxacin compared with imipenem/cilastatin followed by ciprofloxacin in adult patients with nosocomial pneumonia: a multicenter, prospective, randomized, open-label study. Clin. Ther. 25:485-506.